Todd Asset Management LLC Sells 3,886 Shares of Sanofi (NASDAQ:SNY)

Todd Asset Management LLC reduced its position in shares of Sanofi (NASDAQ:SNY) by 0.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 655,108 shares of the company’s stock after selling 3,886 shares during the quarter. Todd Asset Management LLC’s holdings in Sanofi were worth $31,596,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. IFP Advisors Inc increased its stake in Sanofi by 17.2% during the 4th quarter. IFP Advisors Inc now owns 2,132 shares of the company’s stock valued at $103,000 after purchasing an additional 313 shares in the last quarter. Atlantic Family Wealth LLC bought a new stake in Sanofi during the 4th quarter valued at about $262,000. Oxbow Advisors LLC increased its stake in Sanofi by 4.8% during the 4th quarter. Oxbow Advisors LLC now owns 104,749 shares of the company’s stock valued at $5,052,000 after purchasing an additional 4,790 shares in the last quarter. Bank of Stockton increased its stake in Sanofi by 6.0% during the 4th quarter. Bank of Stockton now owns 6,251 shares of the company’s stock valued at $301,000 after purchasing an additional 352 shares in the last quarter. Finally, Transcend Capital Advisors LLC boosted its holdings in shares of Sanofi by 5.3% during the 4th quarter. Transcend Capital Advisors LLC now owns 5,623 shares of the company’s stock valued at $271,000 after acquiring an additional 281 shares during the last quarter. 14.04% of the stock is currently owned by institutional investors.

Sanofi Stock Performance

SNY opened at $53.75 on Tuesday. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The company has a market cap of $136.41 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 1.01 and a beta of 0.57. The company’s 50 day moving average is $51.10 and its 200 day moving average is $52.55. Sanofi has a 12-month low of $45.22 and a 12-month high of $58.97.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. On average, equities research analysts predict that Sanofi will post 4.36 EPS for the current year.

Analysts Set New Price Targets

SNY has been the topic of a number of recent analyst reports. StockNews.com downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Finally, Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.